Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Vaiani

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.
Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Clinical Colorectal Cancer|March 12, 2026
Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement StudyVincenzo Nasca, Gabriele Tinè, Marta Vaiani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2020
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancerPaolo Manca, Salvatore Corallo, Giovanni Randon, et al.
Tumori|June 18, 2017
Eleven-year management of prostate cancer patients on active surveillance: what have we learned?Cristina Marenghi, Maria Francesca Alvisi, Federica Palorini, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal for Immunotherapy of Cancer|April 14, 2021
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitorsGiovanni Fucà, Francesca Corti, Margherita Ambrosini, et al.
Clinical Colorectal Cancer|December 19, 2018
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver MetastasesFilippo Pietrantonio, Christian Cotsoglou, Giovanni Fucà, et al.
Clinical Colorectal Cancer|March 12, 2026
Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement StudyVincenzo Nasca, Gabriele Tinè, Marta Vaiani, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2020
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancerPaolo Manca, Salvatore Corallo, Giovanni Randon, et al.
Tumori|June 18, 2017
Eleven-year management of prostate cancer patients on active surveillance: what have we learned?Cristina Marenghi, Maria Francesca Alvisi, Federica Palorini, et al.
Pageof 2